Evidence suggests an association between depressive disorders and immune and neuroendocrine alterations.1) Cytokines, signaling molecules of the cellular immune system, profoundly influence neuroendocrine processes, thereby promoting affective disorders. [2][3][4] Interleukin (IL) 6 and tumor necrosis factor-alpha (TNF-a), mainly derived from activated macrophages, are pleiotropic cytokines. Increased serum IL-6 levels have been observed in depressed patients, which were reversed after treatment with antidepressant drugs such as fluoxetine.5,6) Elevated circulating TNF-a might be associated with psychiatric illness. 7) In addition to activation of cytokine secretion, a reduction in natural killer (NK) cell activity has also been reported in depressive patients.8) NK cell activity could be reversed by antidepressant drugs concomitant with clinical improvement in patents with depression. 1,9) There are complex reciprocal relationships between immune and hypothalamic-pituitary-adrenal (HPA) axis function in depression.10,11) Elevated cerebrospinal fluid corticotropin-releasing factor (CRF) concentrations and altered regulation of adrenocorticotropin hormone (ACTH) and cortisol secretory activities have been observed in patients with major depression.12) Normalization of these levels occurred after successful antidepressant treatment with fluoxetine.13) On the other hand, some cytokines are known to be potent activators of the HPA axis and involved in the regulation of cortisol and ACTH secretion. It was important to note that animals displaying IL-6-and TNF-a-induced HPA axis sensitization showed signs of marked illness.14,15) In addition, NK cell activity is mediated by pro-inflammatory cytokines, mainly by IL-6 and TNF-a, which in depressed patients appear to be correlated with severity of the disease and hyperactivity of the HPA axis.11,16) These findings indicated that modulation of immune activities appeared to be in part under the control of the HPA axis.16)The rhizomes of Curcuma longa L. (Zingiberaceae), commonly called turmeric, are widely used in food and medicine. Turmeric extracts have been shown to possess powerful antioxidant, anti-inflammatory, lipid-reducing, chemopreventive, immunodulatory, and sedative actions.17,18) Current pharmacological studies show that they may represent a potential therapeutic approach to ameliorate the progression of Alzheimer's disease. [19][20][21] Clinical results have recently suggested that premorbid major depressive disorder is associated with more severe cognitive deficits during the actual course of dementia.22) Our previous study demonstrated that aqueous extracts of C. longa were able to elicit a dose-dependent immobility reduction in the tail suspension test and the forced swimming test in mice, two animal models of depression.23) Curcumin, a major compound of the ethanolic extracts in turmeric, was found to attenuate the monoamine oxidase activity in C6 glial cells. 24) In our continuing efforts to discover a suitable pharmacological therapy for treating depres...